[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session .

Keyword Index: D

[ 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
Darbepoetin alfa
D-dimer
Deep Venous Thrombosis
Deferiprone
996
Defibrotide
Demethylation
Dendritic Cell
Dendritic Cell Vaccine
Depression
Development
Dexamethasone
Diamond-Blackfan Anemia
DIC
Differentiation
Differentiation Therapy
Diffuse Large Cell Lymphoma
Dimerization
Direct Thrombin Inhibitor
Disseminated Intravascular Coagulation
DLI
DNA Damage
DNA Methylation
DNA Microarray
DNA Repair
Dominant Negative Effect
Donor
Donor Lymphocyte Infusion
Dose Intensity
Down Syndrome
Doxorubicin
Drug Interaction
Drug Resistance
Drug Sensitivity
DVT
Dynamic
Dyskeratosis Congenita
Dysplasia
[ 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]